|
ericifolin
|
C521615 |
|
|
2-O-p-hydroxybenzoyl-6-O-galloyl-alpha-4C1-glucopyranose
|
C521616 |
|
|
3-methoxyellagic acid 4-O-rhamnopyranoside
|
C521617 |
|
|
trans-4-(6,7-dimethoxyquinoxalin-2ylamino)cyclohexanol sulfate
|
C521618 |
|
|
bracteanolide B
|
C521619 |
|
|
Squamous Intraepithelial Lesions of the Cervix
|
D065310 |
[A cytological test finding often from PAP SMEARS that shows abnormal lesions of SQUAMOUS EPITHELIAL CELLS of the CERVIX. It is a diagnostic criterion used in the Bethesda System for UTERINE CERVICAL NEOPLASMS and represents the PAP TEST result that is abnormal. Although squamous intraepithelial lesions test result does not mean UTERINE CERVICAL NEOPLASMS it requires follow-ups (e.g., HPV DNA TESTS; and COLPOSCOPY).
] |
|
Adenocarcinoma in Situ
|
D065311 |
[A lesion with cytological characteristics associated with invasive adenocarcinoma but the tumor cells are confined to the GLANDULAR EPITHELIAL CELLS of origin. Adenocarcinoma in situ of the CERVIX and the LUNG are the most common.
] |
|
combretastatin D2
|
C521610 |
|
|
acid red B
|
C521611 |
|
|
planosil
|
C521612 |
|
|
NIP2;1 protein, Arabidopsis
|
C521613 |
|
|
Corneal Injuries
|
D065306 |
[Damage or trauma inflicted to the CORNEA by external means.
] |
|
Morphological and Microscopic Findings
|
D065308 |
[Morphological findings useful in differentiation and classification of results in CYTODIAGNOSIS and related techniques.
] |
|
Atypical Squamous Cells of the Cervix
|
D065309 |
[Morphological abnormalities of the cervical EPITHELIUM, usually revealed in PAP SMEAR, which do not meet the criteria for squamous CERVICAL INTRAEPITHELIAL NEOPLASIA or SQUAMOUS CELL CARCINOMAS of the CERVIX . It may be a sign of infection with certain types of human papillomavirus (HPV).or sign of a benign (not cancer) growth, such as a cyst or polyp or, in menopausal women, of low hormone levels. More testing, such as HPV test, may be needed.
] |
|
cyathusal C
|
C521647 |
|
|
cyathusal B
|
C521648 |
|
|
alboatisin A
|
C521649 |
|
|
phenanthroindolizidine
|
C521640 |
|
|
phenanthroquinolizidine
|
C521641 |
|
|
elecanacin
|
C521642 |
|